This inventor holds 2 USPTO granted patents. Top assignee: Astra Aktiebolag. Active years: 2000-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2005
Title: Umender Sharma: Innovator in Nucleic Acid Technologies
Introduction
Umender Sharma is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid technologies. With a total of 2 patents to his name, Sharma's work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Sharma's latest patents include groundbreaking inventions related to DNA molecules and recombinant vectors. The first patent focuses on novel nucleic acid molecules that code for sigma subunits of RNA polymerase. This invention also encompasses polypeptides, referred to as SigA and SigB, which are encoded by these nucleic acid molecules. Additionally, it provides vectors and host cells transformed with the said nucleic acid molecules. The invention further includes screening assays for compounds that inhibit the interaction between a sigma subunit and core RNA polymerase.
Career Highlights
Umender Sharma is currently employed at Astra Aktiebolag, where he continues to advance his research and development efforts. His work at the company has allowed him to collaborate with other experts in the field, enhancing the scope and impact of his inventions.
Collaborations
Sharma has worked closely with his coworker, Meenakshi Balganesh, to further explore the applications of his research. Their collaboration has fostered a productive environment for innovation and discovery.
Conclusion
Umender Sharma's contributions to nucleic acid technologies exemplify the spirit of innovation in the scientific community. His patents not only advance our understanding of molecular biology but also pave the way for future developments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile